OpenEvidence closed a $75 million Series A round in February 2025 led by Sequoia Capital, which valued the company at $1 billion. The platform enables verified physicians to access referenced, point‑of‑care medical information and is used daily by more than 40 percent of U.S. doctors across over 10,000 medical facilities.